Karolinska Development AB: First Patient Dosed in the Phase I/II Study of Umecrine Mood's Candidate Drug for Premenstrual Dysphoric Disorder Published: May 23, 2013 Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news